99mTc-SY101

N/A

Report date: 2025/09/19 17:03:10
NME

Base Information

Drug Name99mTc-SY101
Drug Alias Name[99mTc]SY10199mTc-SY10199mTcSY101
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo) > Contrast agentRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsContrast agentsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Shiya Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesMitro Biotech Co LtdShanghai Shiya Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsContrast agentsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A